Cosmos Health Inc.

NasdaqCM:COSM Stock Report

Market Cap: US$13.9m

Cosmos Health Management

Management criteria checks 2/4

Cosmos Health's CEO is Greg Siokas, appointed in Feb 2016, has a tenure of 8.83 years. total yearly compensation is $2.88M, comprised of 37.5% salary and 62.5% bonuses, including company stock and options. directly owns 13.35% of the company’s shares, worth $1.85M. The average tenure of the management team and the board of directors is 6.5 years and 4.4 years respectively.

Key information

Greg Siokas

Chief executive officer

US$2.9m

Total compensation

CEO salary percentage37.5%
CEO tenure8.8yrs
CEO ownership13.3%
Management average tenure6.5yrs
Board average tenure4.4yrs

Recent management updates

Recent updates

Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump

Aug 16
Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump

Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

Feb 23
Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch

Cosmos Holdings intends to acquire telemedicine platform ZipDoctor

Sep 28

Cosmos Holdings reports Q2 results

Aug 22

Cosmos changes name to Cosmos Healthto

Jul 29

Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically

Jul 20

Cosmos Holdings to acquire bone health product portfolio from LIFE NLB

Jul 06

CEO Compensation Analysis

How has Greg Siokas's remuneration changed compared to Cosmos Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$34m

Jun 30 2024n/an/a

-US$29m

Mar 31 2024n/an/a

-US$27m

Dec 31 2023US$3mUS$1m

-US$26m

Sep 30 2023n/an/a

-US$43m

Jun 30 2023n/an/a

-US$42m

Mar 31 2023n/an/a

-US$59m

Dec 31 2022US$600kn/a

-US$64m

Sep 30 2022n/an/a

-US$35m

Jun 30 2022n/an/a

-US$35m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021n/an/a

-US$16m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$870k

Dec 31 2020n/an/a

US$821k

Sep 30 2020n/an/a

US$2m

Jun 30 2020n/an/a

-US$648k

Mar 31 2020n/an/a

-US$4m

Dec 31 2019n/an/a

-US$3m

Sep 30 2019n/an/a

-US$13m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018n/an/a

-US$9m

Sep 30 2018n/an/a

-US$2m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$250kn/a

-US$6m

Compensation vs Market: Greg's total compensation ($USD2.88M) is above average for companies of similar size in the US market ($USD651.40K).

Compensation vs Earnings: Greg's compensation has increased whilst the company is unprofitable.

CEO

Greg Siokas (59 yo)

8.8yrs

Tenure

US$2,880,000

Compensation

Mr. Grigorios Siokas, also known as Greg, has been the Chairman and Chief Executive Officer of Cosmos Health Inc. (formerly known as Cosmos Holdings Inc.) since February 26, 2016 and served as its Presiden...

Leadership Team

NamePositionTenureCompensationOwnership
Grigorios Siokas
Chairman & CEO8.8yrsUS$2.88m13.35%
$ 1.9m
Georgios Terzis
Chief Financial Officer4.1yrsUS$435.48k3.05%
$ 423.2k
Nikolaos Bardakis
Chief Operating Officer1.8yrsUS$49.58k0.21%
$ 29.7k
Demetrios Demetriades
Secretary & Independent Director10.9yrsUS$23.76k0.095%
$ 13.2k

6.5yrs

Average Tenure

57yo

Average Age

Experienced Management: COSM's management team is seasoned and experienced (6.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Grigorios Siokas
Chairman & CEO8.8yrsUS$2.88m13.35%
$ 1.9m
Demetrios Demetriades
Secretary & Independent Director10.9yrsUS$23.76k0.095%
$ 13.2k
Manfred Ziegler
Independent Director & Member of Advisory Board2yrsUS$21.26k0.095%
$ 13.2k
Peter Goldstein
Member of Advisory Boardno datano datano data
Anastasios Tzikas
Member of Advisory Board6.1yrsno datano data
Anastasios Aslidis
Independent Director2.7yrsUS$95.04k0.19%
$ 26.4k
John Hoidas
Independent Director8.1yrsUS$38.26k0.095%
$ 13.2k
Panagiotis Zoumboulakis
Member of Advisory Board2.4yrsno datano data
Suhel Bhutawala
Director1.3yrsUS$83.40k0.14%
$ 19.8k
Vassos Efthymiadis
Member of Advisory Boardno datano datano data
Ioannis Dedes
Member of Advisory Boardno datano datano data

4.4yrs

Average Tenure

59yo

Average Age

Experienced Board: COSM's board of directors are considered experienced (4.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 08:01
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cosmos Health Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Howard HalpernTaglich Brothers, Inc.